Acetylcholinesterase inhibitors reduce spreading activation in dementia

Neuropsychologia

Volumn 50, Issue 8, 2012, Pages 2093-2099

  Foster, Paul S ^a,b,c   Branch, Kaylei K ^a   Witt, John C ^c   Giovannetti, Tania ^d   Libon, David ^e   Heilman, Kenneth M ^b   Drago, Valeria ^b,f  

^a MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Murfreesboro Medical Clinic   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e DREXEL UNIVERSITY   (United States)

^f IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Acetylcholinesterase inhibitor; Dementia; Memory; Spreading activation

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL CORTEX; HUMAN; LEXICAL MEMORY; MALE; MEMORY; PSYCHOLOGIC TEST; RELIABILITY; SEMANTIC MEMORY; VERBAL MEMORY; WORD RECOGNITION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHOLINESTERASE INHIBITORS; DEMENTIA; FEMALE; HUMANS; LANGUAGE TESTS; MALE; MIDDLE AGED; SEMANTICS; WORD ASSOCIATION TESTS;

EID: 84862901877     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2012.05.010     Document Type: Article

References (65)

1. Alhainen K., Helkala E.L., Riekkinen P. Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients. Dementia 1993, 4:54-58.
2. Araujo D.M., Lapchak P.A., Robitaille Y., Gauthier S., Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Journal of Neurochemistry 1988, 50:1914-1923.
3. Audenaert K., Brans B., Van Laere K., Lahorte P., Versijpt J., van Heeringen K., et al. Verbal fluency as a prefrontal activation probe: a validation study using 99mTc-ECD brain SPET. European Journal of Nuclear Medicine 2000, 27:1800-1808.
4. Baldo J.V., Shimamura A.P., Delis D.C., Kramer J., Kaplan E. Verbal and design fluency in patients with frontal lobe lesions. Journal of the International Neuropsychological Society 2001, 7:586-596.
5. Bell E.E., Chenery H.J., Ingram J.C.L. Semantic priming in Alzheimer's dementia: esvidence for dissociation of automatic and attentional processes. Brain and Language 2001, 76:130-144.
6. Bentley P., Vuilleumier P., Thiel C.M., Driver J., Dolan R.J. Cholinergic enchancement modulates neural correlates of selective attention and emotional processing. NeuroImage 2003, 20:58-70.
7. Bohnen N.I., Kaufer D.I., Hendrickson R., Ivanco L.S., Lopresti B., Davis J.G., et al. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease. Neuroscience Letters 2005, 380:127-132.
8. Bohnen N.I., Kaufer D.I., Hendrickson R., Ivanco L.S., Lopresti B.J., Koeppe R.A., et al. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76:315-319.
9. Bowen D.M., Allen S.J., Benton J.S., Goodhardt M.J., Haan E.A., Palmer A.M., et al. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. Journal of Neurochemistry 1983, 41:266-272.
10. Bowen D.M., Benton J.S., Spillane J.A., Smith C.C.T., Allen S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. Journal of the Neurological Sciences 1982, 57:191-202.
11. Caramelli P., Chaves M.L., Engelhardt E., Machado J.C., Schultz R.R., Vale F.A., et al. Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian multi-center galantamine study. Arquivos de Neuro-Psiquiatria 2004, 62:379-384.
12. Chertkow H., Bub D., Seidenberg M. Priming and semantic memory loss in Alzheimer's disease. Brain and Language 1989, 36:420-446.
13. Clegg A., Bryant J., Nicholson T., McIntyre L., De Broe S., Gerard K., et al. Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. International Journal of Technology Assessment in Health Care 2002, 18:497-507.
14. Darreh-Shori T., Almkvist O., Guan Z.Z., Garlind A., Strandberg B., Svensson A.L., et al. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology 2002, 59:563-572.
15. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 308:1403.
16. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. Journal of the American Medical Association 1999, 281:1401-1406.
17. Delis D.C., Massman P.J., Butters N., Salmon D.P., Shear P.K., Demadura T., et al. Spatial cognition in Alzheimer's disease: subtypes of global-local impairment. Journal of Clinical and Experimental Neuropsychology 1992, 14:463-477.
18. Dunne M.P., Hartley L.R. Scopolamine and the control of attention in humans. Psycopharmacology 1986, 89:94-97.
19. Eggermann E., Feldmeyer D. Cholinergic filtering in the recurrent excitatory microcircuit of cortical layer 4. Proceedings of the National Academy of Sciences 2009, 106:11753-11758.
20. Evans J.G., Wilcock G., Birks J. Evidence-based pharmacotherapy of Alzheimer's disease. International Journal of Neuropsychopharmacology 2004, 7:351-369.
21. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annual Review of Psychology 1997, 48:649-684.
22. Foldi N.S., White R.E.C., Schaefer L.A. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease. International Journal of Geriatric Psychiatry 2005, 20:485-488.
23. Folstein M.F., Fostein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
24. Foster P.S., Drago V., FitzGerald D.B., Skoblar B.M., Crucian G.P., Heilman K.M. Spreading activation of lexical-semantic networks in Parkinson's disease. Neuropsychologia 2008, 46:1908-1914.
25. Francis W.N., Kucera H. Frequency Analysis of English Usage: Lexicon and Grammar 1982, Houghton Mifflin, Boston, MA.
26. Furey M.L., Pietrini P., Haxby J.V., Drevets W.C. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 2008, 33:913-923.
27. Giffard B., Desgranges B., Nore-Mary F., Lalevee C., de la Sayette V., Pasquier F., et al. The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain 2001, 124:1522-1532.
28. Ginani G.E., Tufik S., Bueno O.F., Pradella-Hallinan M., Rusted J., Pompeia S. Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning. Journal of Psychopharmacology 2011, 25:1508-1516.
29. Glick S.D., Ross D.A., Hough L.B. Lateral asymmetry of neurotransmitters in human brain. Brain Research 1982, 234:53-63.
30. Glosser G., Friedman R.B. Lexical but not semantic priming in Alzheimer's disease. Psychology and Aging 1991, 6:522-527.
31. Gorus E., De Raedt R., Lambert M., Lemper J.C., Mets T. Attentional processes discriminate between patients with mild Alzheimer's disease and cognitively healthy elderly. International Psychogeriatrics 2006, 18:539-549.
32. Gorus E., Lambert M., De Raedt R., Mets T. The influence of galantamine on reaction time, attention processes, and performance variability in elderly Alzheimer's patients. Journal of Clinical Psychopharmacology 2007, 27:182-187.
33. Gourovitch M.L., Kirkby B.S., Goldberg T.E., Weinberger D.R., Gold J.M., Esposito G., et al. A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology 2000, 14:353-360.
34. Henry J.D., Crawford J.R. A meta-analytic review of verbal fluency performance in patients with traumatic brain injury. Neuropsychology 2004, 18:621-628.
35. Herholz K., Bauer B., Wienhard K., Kracht L., Mielke R., Lenz O., et al. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. Journal of Neural Transmission 2000, 107:1457-1468.
36. Herholz K., Weisenbach S., Kalbe E., Diederich N.J., Heiss W.D. Cerebral acyetylcholine esterase activity in mild cognitive impairment. NeuroReport 2005, 16:1431-1434.
37. Kaasinen V., Nagren K., Jarvenpaa T., Roivainen A., Yu M., Oikonen V., et al. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. Journal of Clinical Psychopharmacology 2002, 22:615-620.
38. Kadir A., Darreh-Shori T., Almkvist O., Wall A., Grut M., Strandberg B., et al. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging 2008, 29:1204-1217.
39. Kasa P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Progress in Neurobiology 1997, 52:511-535.
40. Klinkengerg I., Sambeth A., Blokland A. Acetylcholine and attention. Behavioural Brain Research 2011, 221:430-442.
41. Kononenko V.S. Cholinesterase activity of nerve tissue as an indicator of asymmetry of brain centers. Human Physiology 1980, 6:434-439.
42. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacology Biochemistry and Behavior 1997, 56:687-696.
43. Nebes R.D., Martin D.C., Horn L.C. Sparing of semantic memory in Alzheimer's disease. Journal of Abnormal Psychology 1984, 93:321-330.
44. Ober B.A., Shenaut G.K. Lexical decision and priming in Alzheimer's disease. Neuropsychologia 1988, 26:273-286.
45. Ober B.A., Shenaut G.K., Jagust W.J., Stillman R.C. Automatic semantic priming with various category relations in Alzheimer's disease and normal aging. Psychology and Aging 1991, 6:647-660.
46. Parasuraman R., Haxby J.V. Attention and brain function in Alzheimer's disease: a review. Neuropsychology 1993, 7:242-272.
47. Perry R.J., Hodges J.R. Attention and executive deficits in Alzheimer's disease: a critical review. Brain 1999, 122:383-404.
48. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal 1978, 2:1457-1459.
49. Rogers S.L., Friedman R.B. The underlying mechanisms of semantic memory loss in Alzheimer's disease and semantic dementia. Neuropsychologia 2008, 46:12-21.
50. Rossor M.N., Iversen L.L., Reynolds G.P., Mountjoy C.Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. British Medical Journal 1984, 288:961-964.
51. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L., et al. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 1993, 110:395-401.
52. Salloway S., Ferris S., Kluger A., Goldman R., Griesing T., Kumar D., et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004, 63:651-657.
53. Salmon D.P., Shimamura A.P., Butters N., Smith S. Lexical and semantic priming deficits with Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology 1988, 10:477-494.
54. Saumier D., Murtha S., Bergman H., Phillips N., Whitehead V., Chertkow H. Cognitive predictors of donepezil therapy response in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2007, 24:28-35.
55. Shinotoh H., Namba H., Fukushi K., Nagatsuka S.I., Tanaka N., Aotsuka A., et al. Brain acetylcholinesterase activity in Alzheimer disease measured by positron emission tomography. Alzheimer Disease and Associated Disorders 2000, 14(Suppl. 1):S114-S118.
56. Shinotoh H., Namba H., Fukushi K., Nagatsuka S.I., Tanaka N., Aotsuka A., et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. Annals of Neurology 2000, 48:194-200.
57. Silveri M.C., Monteleone D., Burani C., Tabossi P. Automatic semantic facilitation in Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology 1996, 18:371-382.
58. Slavin M.J., Mattingley J.B., Bradshaw J.L., Storey E. Local-global processing in Alzheimer's disease: an examination of interference, inhibition and priming. Neuropsychologia 2002, 40:1173-1186.
59. Stuss D.T., Alexander M.P., Hamer L., Palumbo C., Dempster R., Binns M., et al. The effects of focal anterior and posterior brain lesions on verbal fluency. Journal of the International Neuropsychological Society 1998, 4:265-278.
60. Thomas D.A., Libon D.J., Ledakis G.E. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis. Applied Neuropsychology 2005, 12:12-18.
61. Vellas B., Cunha L., Gertz H.J., De Deyn P.P., Wesnes K., Hammond G., et al. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. Current Medical Research and Opinion 2005, 9:1423-1429.
62. Voytko M.L. Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?. Behavioural Brain Research 1996, 75:13-25.
63. Wood A.G., Saling M.M., Abbott D.F., Jackson G.D. A neurocognitive account of frontal lobe involvement in orthographic lexical retrieval: an fMRI study. NeuroImage 2001, 14:162-169.
64. Winer B.J. Statistical principles in experimental design (2nd ed.) 1971, McGraw-Hill, New York.
65. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research 1983, 17:37-49.